Novo Nordisk sues Eli Lilly, accusing it of false advertising
The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more effective than Novo's.
Novo Nordisk
FDA warns Novo Nordisk over unreported potential Ozempic side effects
The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects.
Novo Nordisk to slash Wegovy and Ozempic prices starting in 2027
Starting in 2027, the Danish pharma firm will sell its weight-loss and diabetes drugs for $675 per month.
Novo Nordisk debuts Wegovy weight-loss pill in the U.S.
FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo Nordisk.
FDA approves Wegovy pill for weight loss
The Food and Drug Administration has approved a pill version of the weight-loss drug Wegovy.
FDA approves weight loss drug in daily pill form
Regulators at the U.S. Food and Drug Administration gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication approved to treat obesity. Dr. Jon LaPook has more.
Novo Nordisk slashes out-of-pocket prices for Wegovy and Ozempic
The Danish drugmaker said it's cutting the price of Wegovy and Ozempic from $499 to $349 per month for some customers who buy the drugs directly.
Details on lower weight loss drugs prices
President Trump announced a deal on Thursday that will lower the cost of some weight loss drugs for certain eligible Americans. CBS News medical contributor Dr. Celine Gounder explains the details of the deal and how much Americans can expect to pay.
Trump announces deal to lower weight loss drug prices in some cases
The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month in some cases, officials said.
Trump unveils deal to cut weight loss drug prices
President Trump announced a deal to drastically lower the price of weight loss drugs for some Americans. Dr. Jon LaPook has more.
Novo Nordisk CEO on Trump drug prices deal
President Trump on Thursday unveiled agreements slashing the prices of two pharmaceutical companies' weight loss drugs. Novo Nordisk CEO Mike Doustdar joins "The Takeout" to unpack the cost-cutting effort.
Costco now sells Ozempic and Wegovy at its pharmacies
A one-month supply of Ozempic and Wegovy will now cost $499 out of pocket for Costco shoppers.
Wegovy maker Novo Nordisk says it's cutting 9,000 workers
Novo Nordisk said the job cuts will eliminate about 11% of its workforce, with 5,000 of the reductions in Denmark.
Inside the weight loss drug price war
The maker of Ozempic is cutting the price of the drug nearly in half for some patients. Novo Nordisk had already cut the price of Wegovy, a medication with the same active ingredient that's approved for weight loss. Dr. Celine Gounder has more on the emerging price competition over the drugs.
Novo Nordisk ends Wegovy sales on Hims & Hers over "deceptive marketing"
Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.
Novo Nordisk CEO, who led company into weight-loss drugs, to step down
Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual agreement."
Meet the scientist behind Ozempic, Wegovy
Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide — while adding great heft to the economy of Novo Nordisk’s home country, Denmark.
With Novo Nordisk success, is there a "Nokia risk" for Denmark?
Correspondent Jon Wertheim revisits 60 Minutes' coverage of former mobile giant Nokia and discusses potential risks for the Danish economy.
How a love story launched the company behind Ozempic, Wegovy
Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, were looking for a way to tackle diabetes, which the wife suffered from.
Doctors explain how Wegovy and Ozempic work
The semaglutide injections have grown in popularity as a mechanism to help with weight loss for type 2 diabetes and obesity diagnoses.
Live
Saudi airport stays shut as Houthi attacks kill 20 people in a week
Trump says he's "looking at" firing Kimberly Guilfoyle
Rep. Omar's D.C. home searched by DHS investigators
Talarico was at home in Texas during campaign trail absence, photos indicate
Emergency help for Christa Pike was delayed, 911 calls show
Military's archbishop criticizes plan to livestream execution
RJ Mitte, "Breaking Bad" actor, dies at 34
1 dead in incident on Six Flags Over Georgia roller coaster
